학술논문
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, May 2023, 184:1-9)
Subject
Language
English
ISSN
18790852
09598049
09598049